Age, biological sex, and human genetic factors influence the production of antibodies during the immune response. A team of scientists from the Institut Pasteur, the CNRS and the Collège de France have shown that these factors determine not only the quantity of antibodies produced but also the specific viral regions they target. This discovery could have major implications for the development of treatments that are better tailored to each individual’s profile. The research was published in the journal Nature Immunology on February 16, 2026.
This article was originally published on MedicalXpress.com
